Company Overview

JHS Svendgaard Laboratories Limited stands as a leading FMCG company specializing in innovative oral care products, offering premium toothpaste, toothbrushes, and personal care solutions from India's trusted brand. The Company was incorporated on October 8, 2004, in Himachal Pradesh by the Registrar of Companies, Punjab, Himachal Pradesh & Chandigarh, situated at Jalandhar. Its main object is to manufacture and/or trade in dental/oral care products, including toothbrushes, toothpaste, tooth powder, mouth rinse, whitening gel, effervescent tablets, and tongue cleaners.

The company's journey began with humble beginnings, starting as a small-scale enterprise in August 1997 under Sunehari Svendgaard Laboratories Limited, before being incorporated as JHS Svendgaard Laboratories Limited on October 8, 2004. By April 2005, the company took over businesses from Sunehari Svendgaard Laboratories Limited, Sunehari Oral Care, and Jai Hanuman Exports.

Business Operations and Product Portfolio

JHS Svendgaard Laboratories Limited is an India-based private label manufacturer of oral care products. The Company is engaged in manufacturing a range of oral and dental products for national and international brands. Its segments include toothbrushes, toothpastes, talcum, and others, with the toothbrushes segment generating key revenue.

Starting with the manufacturing of only toothbrushes, the company widened its scope to toothpastes, mouthwash, and denture tablets, and today is a comprehensive oral care product manufacturer and exporter. Apart from working on its own brands like Dr. Gold and Aquawhite, the company also offers Contract Manufacturing Partnerships to brands in the domestic and international markets.

The company has expanded its vision beyond traditional oral care products. With a new aim and fresh ideas, it has embarked on a journey to widen its horizons and delve into the complete FMCG/personal care sector. This involves modifying its perception, capabilities, scope, and resources to become a capable and competent FMCG Company.

Manufacturing Excellence and Quality Standards

JHS Svendgaard Laboratories Limited manufactures its entire range of oral care products at its ISO-certified, state-of-the-art manufacturing facilities located in Kala Amb, Himachal Pradesh. The company has expanded its production capacity from 1.5 crore to 24.62 crore units over the past 15 years.

JHS' well-established research and development department strives for constant innovation and high-quality oral products, ensuring the company is well-prepared for future challenges. The company also possesses complete in-house process facilities, from injection molding to bristling and packaging, to ensure strict quality control.

The presence of a fully equipped Quality Control (QC) laboratory with the latest gadgets, combined with state-of-the-art Vertical & Injection Molding machines from Demag and Cincinnati, Tufting & Trimming machines from Anton Zahoransky GmbH, Germany, and Blister Packing Machines, ensures international quality of products.

Global Market Presence

The company's geographical segments include India, UAE, Italy, Nepal, Russia, and the USA, with the majority of revenue generated from India. JHS Svendgaard Laboratories Ltd also holds Star Export House status and has established subsidiary companies in the UAE and India. This international presence demonstrates the company's commitment to expanding its global footprint while maintaining its strong domestic market position.

Financial Performance and Market Position

As of July 9, 2025, the market capitalization of JHS Svendgaard Laboratories Ltd (JHS) is ₹110.17 Cr. The company has faced challenging market conditions, with its market cap showing volatility throughout the year.

Q4 FY25 Financial Highlights:

- Revenue: ₹25.17 Cr as on March 2025 (Q4 FY25)

- Net Profit: ₹-6.96 Cr as on March 2025 (Q4 FY25)

- Sales rose 16.20% to ₹25.17 crore in the quarter ended March 2025, compared to ₹21.66 crore in the previous quarter ended March 2024.

Annual Performance FY25:

- Sales rose 29.94% to ₹92.00 crore in the year ended March 2025, against ₹70.80 crore in the previous year ended March 2024.

- For the full year, a net loss of ₹19.74 crore was reported in the year ended March 2025, compared to a net loss of ₹4.06 crore in the previous year ended March 2024.

Shareholding Structure and Corporate Governance

- Promoter Holding: 34.6% (as per the latest available data, showing a stable promoter holding as of Mar 2025 from Aug 2024). This indicates management confidence in the business.

- Managing Director: Nikhil Nanda.

- Recent Corporate Governance Updates: Re-appointment of MD Nikhil Nanda from July 2, 2025; Independent Director Mukul Pathak's tenure ended July 1, 2025.

Stock Market Performance

The stock has experienced significant volatility. The 52-week high for JHS Svendgaard Laboratories Ltd (JHS) is ₹32.69, and the 52-week low is ₹11. Over the past 6 months, the JHS Svendgaard Laboratories share price has decreased by 34.9%, and in the last one year, it has decreased by 39.68%.

The company faces certain operational challenges, with a poor sales growth of -7.94% over the past five years. However, it maintains a strong balance sheet position as the company is almost debt-free.

Industry Recognition and Future Outlook

JHS Svendgaard is regularly recognized for its quality, receiving awards such as the 'Best Performing Enterprise Award Runner-up - Turnover from Rs 26 to 100 crore' at Plasticon Awards 2009. Through various mergers and acquisitions, the company now has a presence in retail investments and continues to innovate, providing the highest quality oral hygiene products to Indian and global markets.

The company continues to focus on innovation and expansion in the FMCG sector while leveraging its strong manufacturing capabilities and established market presence in the oral care segment.